Efficacy of endovascular thrombectomy in patients with M2 segment middle cerebral artery occlusions: meta-analysis of data from the HERMES Collaboration
Top Cited Papers
- 11 April 2019
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 11 (11), 1065-1069
- https://doi.org/10.1136/neurintsurg-2018-014678
Abstract
Background The Society of Neurointerventional Surgery revised its operational definition of emergent large vessel occlusion (ELVO) recently to include proximal M2 segment middle cerebral artery (MCA) occlusions. We sought to assess the benefit of endovascular thrombectomy (EVT) over best medical care for M2 segment MCA occlusion. Methods Patient level data from trials in the HERMES Collaboration were included. The HERMES core laboratory identified patients with M2 segment MCA occlusions and further classified them as proximal versus distal, anterior versus posterior division, and dominant versus co-dominant versus non-dominant. Primary outcome was modified Rankin Scale (mRS) score 0–2 at 90 days. Secondary outcomes were modified Thrombolysis in Cerebral Infarction (mTICI) rates at end of procedure, 90-day mRS shift, 90-day mRS 0–1, 24 hours National Institute of Health Stroke Scale (NIHSS) score 0–2, symptomatic intracerebral hemorrhage (ICH), and death. Results 130 patients with M2 MCA (proximal location n=116 vs distal n=14, anterior division n=72 vs posterior n=58, dominant n=73 vs co-dominant n=50 vs non-dominant n=7) were included. Successful reperfusion (mTICI 2b or 3) among those undergoing EVT was seen in 59.2% of patients. Treatment effect favored EVT (adjusted OR 2.39, 95% CI 1.08 to 5.28, p=0.03) for 90-day mRS 0–2 (58.2% EVT vs 39.7% control). Direction of benefit favored EVT for other outcomes. Treatment effect favoring EVT was maximal in patients with proximal M2 segment MCA occlusions (n=116, adjusted OR 2.68, 95% CI 1.13 to 6.37) and in dominant M2 segment MCA occlusions (n=73, adjusted OR 4.08, 95% CI 1.08 to 15.48). No sICH (0%) was observed in patients treated with EVT compared with five (7.9%) in the control arm. Conclusion Patients with proximal M2 segment MCA occlusions eligible for EVT trial protocols benefited from EVT.Keywords
This publication has 17 references indexed in Scilit:
- Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level dataThe Lancet Neurology, 2018
- ELVO: an operational definitionJournal of NeuroInterventional Surgery, 2018
- Mechanical thrombectomy for acute ischemic stroke with occlusion of the M2 segment of the middle cerebral artery: a meta-analysisJournal of NeuroInterventional Surgery, 2017
- Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the Middle Cerebral Artery M2 SegmentJAMA Neurology, 2016
- Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysisJAMA, 2016
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trialsThe Lancet, 2016
- What constitutes the M1 segment of the middle cerebral artery?Journal of NeuroInterventional Surgery, 2016
- Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic strokeThe Lancet Neurology, 2015
- Role of Imaging in Current Acute Ischemic Stroke Workflow for Endovascular TherapyStroke, 2015
- The Impact of Recanalization on Ischemic Stroke OutcomeStroke, 2007